Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential

Area of Science:

• Immunology
• Molecular Biology
• Autoimmunity

Background:

• Autoimmunity against nucleic acid-protein complexes like nucleosomes and spliceosomes is common in systemic autoimmune diseases.
• The precise mechanisms driving autoimmunity against these complexes are not fully understood.
• Evidence suggests nucleic acids act as adjuvants, activating immune receptors and potentially initiating autoimmune responses.

Purpose of the Study:

• To provide a comprehensive overview of nucleic acid-associated autoantigens.
• To describe their structure, biological function, and pathogenic importance.
• To discuss recent advances in immunotherapy for these conditions.

Main Methods:

• Review of existing literature on nucleic acid-associated autoantigens.
• Analysis of mechanisms involving nucleic acid sensing receptors and apoptosis.
• Discussion of current and emerging immunotherapeutic strategies.

Main Results:

• Nucleic acid components can act as co-stimulators via Toll-like receptor activation.
• Dysregulated apoptosis and receptor stimulation can lead to loss of self-tolerance.
• This mechanism is implicated in systemic lupus erythematosus and potentially other systemic autoimmune diseases.

Conclusions:

• Autoimmunity to nucleic acid-protein complexes is a hallmark of systemic autoimmune diseases.
• Activation of nucleic acid-sensing receptors is a critical pathway in their development.
• Antigen-specific immunotherapies targeting nucleic acid-binding antigens show promise.